Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios.
10.3803/EnM.2016.31.2.277
- Author:
Jung Hee KIM
1
;
Kyeong Seon PARK
;
A Ram HONG
;
Chan Soo SHIN
;
Seong Yeon KIM
;
Sang Wan KIM
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. swkimmd@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Captopril challenge test;
Aldosterone-to-renin ratio;
Plasma aldosterone concentrations;
Screening test;
Primary aldosteronism
- MeSH:
Aldosterone;
Captopril*;
Diagnosis;
Hospitalization;
Humans;
Hyperaldosteronism;
Hypertension;
Mass Screening;
Odds Ratio;
Plasma;
Prospective Studies;
Sensitivity and Specificity;
Treatment Outcome
- From:Endocrinology and Metabolism
2016;31(2):277-283
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Diagnosis of primary aldosteronism (PA) begins with aldosterone-to-renin ratio (ARR) measurement followed by confirmative tests. However, the ARR has high false positive rates which led to unnecessary confirmatory tests. Captopril challenge test (CCT) has been used as one of confirmatory tests, but the accuracy of it in the diagnosis of PA is still controversial. We aimed to examine the clinical efficacy of CCT as a post-screening test in PA. METHODS: In a prospective study, we enrolled subjects with suspected PA who had hypertension and ARR >20 (ng/dL)/(ng/mL/hr). Sixty-four patients who underwent both the saline infusion test and the CCT were included. RESULTS: The diagnostic performance of plasma aldosterone concentration (PAC) post-CCT was greater than that of ARR post-CCT and ARR pre-CCT in PA (area under the curve=0.956, 0.797, and 0.748, respectively; P=0.001). A cut-off value of 13 ng/dL showed the highest diagnostic odds ratio considering PAC post-CCT at 60 and 90 minutes. A PAC post-CCT of 19 ng/dL had a specificity of 100%, which can be used as a cut-off value for the confirmative test. Determining the diagnostic performance of PAC post-CCT at 90 minutes was sufficient for PA diagnosis. Subjects with PAC post-CCT at 90 minutes <13 ng/dL are less likely to have PA, and those with PAC post-CCT at 90 minutes ≥13 but <19 ng/dL should undergo secondary confirmatory tests. CONCLUSION: The CCT test may be a reliable post-screening test to avoid the hospitalization in the setting of falsely elevated ARR screening tests.
